Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 91³Ô¹Ï Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
MicroRNAs (miRNAs) are small noncoding RNA gene products about 18 to 24-nt-long. Mainly they negatively regulate
protein expression of specific mRNA by either translational inhibition or mRNAs degradation. Mature miRNAs are the
results of successive processing of primary transcripts (pri-miRNAs) which are facilitated by two RNase III enzymes, Drosha
and Dicer with a characteristic hairpin secondary structure. Reporting of the aberrant expressions of miRNAs have been done
in respect to different human diseases mainly in concern with cancer viz., lung cancer, brain cancer, chronic lymphocytic
leukemia, neurodegenerative diseases etc. It is well established fact that miRNAs defines the expression patterns of the tissuespecificity.
Neurodegenerative disease states the physiological nature of the cell, expression of miR-29a, miR-29b-1 and miR-9
are found significantly down regulated in Alzheimer�s disease. Biopsies of tumor from Parkinson�s disease patients exposed
association of miR-30b, miR-30c and miR-26a. Phylogenetic analysis of miRNA of Alzheimer and Huntington diseases gives
insight into evolutionary relationship and reveals regulation of Mir-22, Mir 29a and mir-128-1 in both diseases. Mir-22 shows
down-regulation in Parkinson disease and Alzheimer disease while mir-128-1 and mir-29a shows the difference in their
regulation pattern. In Alzheimer disease mir-128-1 is up regulated while in Huntington disease it is down regulated. Mir-29a is
up regulated in Huntington disease while in Alzheimer disease, it is down regulated. These findings illustrates the importance
of miRNA research in neurodegenerative diseases with reference to novel targets identification which can give a better lead in
concern to protective or prophylective approaches.
Biography
Prachi Srivastava has completed her PhD under a collaborative project of IITR and KGMU Lucknow in the area of Eales’ Disease Diabetic Retinopathy and Uveitis. She has completed Doctorate degree from Lucknow University. She has served as an Academician and also as honorary Biotechnology Counsellor. She has many awards and publications to her credit. She is a Member of many national and international societies and Reviewer and Editorial Team Member of many reputed journals.